Skip to main navigation Skip to search Skip to main content

Chromium picolinate improves insulin sensitivity in obese subjects with polycystic ovary syndrome

  • Michael L. Lydic
  • , Margaret McNurlan
  • , Shirley Bembo
  • , Lina Mitchell
  • , Eugene Komaroff
  • , Marie Gelato
  • Stony Brook University

Research output: Contribution to journalArticlepeer-review

43 Scopus citations

Abstract

Trivalent chromium (1000 μg), as chromium picolinate, given without change in diet or activity level, caused a 38% mean improvement in glucose disposal rate in five obese subjects with polycystic ovary syndrome who were tested with a euglycemic hyperinsulinemic clamp technique. This suggests that chromium picolinate, an over-the-counter dietary product, may be useful as an insulin sensitizer in the treatment of polycystic ovary syndrome.

Original languageEnglish
Pages (from-to)243-246
Number of pages4
JournalFertility and Sterility
Volume86
Issue number1
DOIs
StatePublished - Jul 2006

Fingerprint

Dive into the research topics of 'Chromium picolinate improves insulin sensitivity in obese subjects with polycystic ovary syndrome'. Together they form a unique fingerprint.

Cite this